About Contact Us Careers
Sign In

Direct-Acting Antiviral Medicines Market - Top Companies and Manufacturers

  • Report ID: 3005
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Direct-Acting Antiviral Medicines Landscape

    • AbbVie, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Janssen Therapeutics
    • Bristol-Myers Squibb
    • Merck & Co.
    • Vertex Pharmaceuticals
    • Johnson & Johnson
    • Gilead Sciences, Inc.
    • Natco Pharma
    • Dr. Reddy’s Laboratories
Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 3005
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Direct-Acting Antiviral Medicines Market size is likely to register remarkable growth rate during the forecast period i.e., between 2025-2037.

Increasing prevalence of liver cirrhosis and hepatocellular carcinoma and the growing investment in the development of advanced therapies will drive the market growth.

Asia Pacific industry is set to account for largest revenue share by 2037, owing to increasing hepatitis C infection prevalence and rising focus of major companies for expanding their product to countries in the region.

The major players in the market are AbbVie, Inc., Janssen Therapeutics, Bristol-Myers Squibb, and Merck & Co., among others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample